Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.

By E. B. Souto, S. Wissing, C. M. Barbosa, R. Müller. International journal of pharmaceutics, 2004

703 citations recorded by the source corpus.

Subfields: Molecular Biology, Pharmaceutical Science

View Paper: https://www.semanticscholar.org/paper/95d120a50f76a637fd1d79b225a3570219038712

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. D. McClements
2. E. Decker
3. J. Weiss
4. R. Müller
5. Wolfgang Becker
6. M. Üner
7. G. Yener

In Pharmaceutical Science

1. D. McClements
2. J. Weiss
3. E. Decker
4. R. Müller
5. Surajit Das
6. Anumita Chaudhury
7. M. Üner
8. G. Yener

Citations in the corpus

• Nanoparticles and microparticles for skin drug delivery. (2011, positive): “This could be explained by the drug leaving the outer particle surface, leaving a high concentration of drug in the core [20,194,195].”
• Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System (2009, neutral): “The NLCs have mainly been investigated in the topical and dermatological preparations[10] in the delivery of clotrimazole[11,12], ketoconazole[13], other antifungal imidazoles[14] and ascorbyl palmitate[9].”
• Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages (2018, neutral): “Finally, the obtained oil in water emulsion is cooled down to room temperature to solidify SLNs or NLCs (17).”
• Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives (2007, neutral): “…1999), tocopherol acetate (Wissing and Müller 2001), retinol (Jenning et al 2000a), ascorbyl palmitate (Üner et al 2005a and 2005b), clotrimazole (Souto et al 2004), triptolide (Mei et al 2003), phodphyllotoxin (Chen et al 2006) and a nonsteroidal antiandrogen RU 58841 (Münster et al 2005) for…”
• Structural Design Principles for Delivery of Bioactive Components in Nutraceuticals and Functional Foods (2009, positive): “Emulsions containing SLP are usually formed using the “hot homogenization” procedure that involves homogenizing an oil and water phase together in the presence of a hydrophilic emulsifier at a temperature above the melting point of the lipid phase (Schubert and Muller-Goymann, 2005; Wissing et al., ”
• Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. (2009, background): “Conequently Souto et al., found a higher occlusive factor for SLN in omparison to NLC of the same lipid content (Souto et al., 2004a). omparing NLC with different oil content led to the conclusion that n increase in oil content leads to a decrease of the occlusive factor Teeranachaideekul et al.,…”